TollereBio
PrivateCompany Overview
TollereBio is a biotechnology company that develops accessible, cost-effective vaccine adjuvants using its proprietary bacterial enzymatic combinatorial chemistry (BECC) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TollereBio Comparables
Compare TollereBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inimmune | 81% | |
| ImmunAdd Inc. | 81% | |
| Adjuvance Technologies | 80% |
For institutional investors. Book with your work email.
TollereBio Funding Rounds
Historical fundraising activity
TollereBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TollereBio's valuation, stock price, and market status.
Is TollereBio a public or private company?
TollereBio is a private company.
What is the current stock price of TollereBio?
TollereBio is a private company, so its shares have no public market price. Caplight tracks TollereBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TollereBio worth (valuation)?
Valuation information for TollereBio is not publicly available.
Can I buy TollereBio stock?
TollereBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TollereBio's last funding round?
Funding round information for TollereBio is not publicly available.
Who are the main investors in TollereBio?
Investor information for TollereBio is not publicly disclosed.
Will TollereBio IPO soon?
No public IPO plans have been announced for TollereBio.
How can I track TollereBio secondary market activity?
Caplight tracks bids, offers, and trades in TollereBio's shares on secondary markets.